Literature DB >> 20553488

Post-translational modification of the deubiquitinating enzyme otubain 1 modulates active RhoA levels and susceptibility to Yersinia invasion.

Mariola J Edelmann1, Holger B Kramer, Mikael Altun, Benedikt M Kessler.   

Abstract

Microbial pathogens exploit the ubiquitin system to facilitate infection and manipulate the immune responses of the host. In this study, susceptibility to Yersinia enterocolitica and Yersinia pseudotuberculosis invasion was found to be increased upon overexpression of the deubiquitinating enzyme otubain 1 (OTUB1), a member of the ovarian tumour domain-containing protein family. Conversely, OTUB1 knockdown interfered with Yersinia invasion in HEK293T cells as well as in primary monocytes. This effect was attributed to a modulation of bacterial uptake. We demonstrate that the Yersinia-encoded virulence factor YpkA (YopO) kinase interacts with a post-translationally modified form of OTUB1 that contains multiple phosphorylation sites. OTUB1, YpkA and the small GTPase ras homologue gene family member A (RhoA) were found to be part of the same protein complex, suggesting that RhoA levels are modulated by OTUB1. Our results show that OTUB1 is able to stabilize active RhoA prior to invasion, which is concomitant with an increase in bacterial uptake. This effect is modulated by post-translational modifications of OTUB1, suggesting a new entry point for manipulating Yersinia interactions with the host.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20553488     DOI: 10.1111/j.1742-4658.2010.07665.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  39 in total

1.  DNA repair: Blocking ubiquitin transfer.

Authors:  April Rose; Christian Schlieker
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

Review 2.  Otubain 1: a non-canonical deubiquitinase with an emerging role in cancer.

Authors:  Matthew Saldana; Kacey VanderVorst; Anastasia L Berg; Hyun Lee; Kermit L Carraway
Journal:  Endocr Relat Cancer       Date:  2019-01-01       Impact factor: 5.678

3.  Identifying recent adaptations in large-scale genomic data.

Authors:  Sharon R Grossman; Kristian G Andersen; Ilya Shlyakhter; Shervin Tabrizi; Sarah Winnicki; Angela Yen; Daniel J Park; Dustin Griesemer; Elinor K Karlsson; Sunny H Wong; Moran Cabili; Richard A Adegbola; Rameshwar N K Bamezai; Adrian V S Hill; Fredrik O Vannberg; John L Rinn; Eric S Lander; Stephen F Schaffner; Pardis C Sabeti
Journal:  Cell       Date:  2013-02-14       Impact factor: 41.582

4.  The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1.

Authors:  Johanna Bialas; Annika N Boehm; Nicola Catone; Annette Aichem; Marcus Groettrup
Journal:  J Biol Chem       Date:  2019-02-04       Impact factor: 5.157

5.  Regulation of Yersinia protein kinase A (YpkA) kinase activity by multisite autophosphorylation and identification of an N-terminal substrate-binding domain in YpkA.

Authors:  Khavong Pha; Matthew E Wright; Tasha M Barr; Richard A Eigenheer; Lorena Navarro
Journal:  J Biol Chem       Date:  2014-08-01       Impact factor: 5.157

Review 6.  Deubiquitinating enzyme regulation of the p53 pathway: A lesson from Otub1.

Authors:  Xiao-Xin Sun; Mu-Shui Dai
Journal:  World J Biol Chem       Date:  2014-05-26

7.  Amyloid aggregates of the deubiquitinase OTUB1 are neurotoxic, suggesting that they contribute to the development of Parkinson's disease.

Authors:  Raniki Kumari; Roshan Kumar; Sanjay Kumar; Abhishek Kumar Singh; Pranita Hanpude; Deepak Jangir; Tushar Kanti Maiti
Journal:  J Biol Chem       Date:  2020-01-31       Impact factor: 5.157

8.  OTUB1 promotes esophageal squamous cell carcinoma metastasis through modulating Snail stability.

Authors:  Honghong Zhou; Yongshuo Liu; Rui Zhu; Fang Ding; Xiufeng Cao; Dongxin Lin; Zhihua Liu
Journal:  Oncogene       Date:  2018-03-21       Impact factor: 9.867

9.  Use of focused ultrasonication in activity-based profiling of deubiquitinating enzymes in tissue.

Authors:  Bindu Nanduri; Leslie A Shack; Aswathy N Rai; William B Epperson; Wes Baumgartner; Ty B Schmidt; Mariola J Edelmann
Journal:  Anal Biochem       Date:  2016-09-20       Impact factor: 3.365

Review 10.  Deubiquitinating enzymes as promising drug targets for infectious diseases.

Authors:  Bindu Nanduri; Akamol E Suvarnapunya; Malabi Venkatesan; Mariola J Edelmann
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.